Compounds > 1-phenyl-2-decanoylamino-3-morpholino-1-propanol

1-phenyl-2-decanoylamino-3-morpholino-1-propanol and epidermal growth factor

1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with epidermal growth factor in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bremer, EG; George, D; Inokuchi, JI; Mania-Farnell, B; Meuillet, EJ1
Berra, B; Colombo, I; Sottocornola, E1

Other Studies

2 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and epidermal growth factor

ArticleYear
Modulation of EGF receptor activity by changes in the GM3 content in a human epidermoid carcinoma cell line, A431.
    Experimental cell research, 2000, Apr-10, Volume: 256, Issue:1

    Topics: Carcinoma, Squamous Cell; Cell Division; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; G(M3) Ganglioside; Gangliosides; Glucosyltransferases; Humans; Kinetics; Morpholines; Signal Transduction; Tumor Cells, Cultured

2000
GM3 content modulates the EGF-activated p185c-neu levels, but not those of the constitutively activated oncoprotein p185neu.
    Biochimica et biophysica acta, 2003, Dec-30, Volume: 1635, Issue:2-3

    Topics: Animals; Cell Line; Cell Line, Tumor; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Female; G(M3) Ganglioside; Mice; Morpholines; Mutation; Receptor, ErbB-2

2003